Published in Medical Letter on the CDC and FDA, August 27th, 2006
Study 1: The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.
According to an international team of researchers, "The urinary tract functions in close proximity to the outside environment, yet must remain free of microbial colonization to avoid disease. The mechanisms for establishing an antimicrobial barrier in this area are not completely understood. We describe the production and function of the cathelicidin antimicrobial peptides LL-37, its precursor hCAP-18, and its ortholog CRAMP in epithelial cells of human and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.